The shadow of generic competition has long loomed above copyright’s famous drug, Viagra, sparking questions about the outlook of similar drug ventures. While initial periods saw significant returns, the patent expiration has created the path for discounted copies, likely reducing revenue and posing a significant danger for investors pursuing stab